Position in INCY
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$7,600,660
+$3,506,348 QoQ
Shares Held
80,755
+94.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $182,532,224 across 11 Biotechnology names. INCY ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,567 | $45,800,268 | |
| 2 | RPRX |
Royalty Pharma plc
|
776,642 | $37,255,516 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
35,939 | $27,767,908 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
64,595 | $21,372,547 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
109,134 | $20,631,782 | |
| 6 | INSM |
INSMED Inc
|
90,826 | $14,851,867 | |
| 7 | INCY |
Incyte Corp
This page
|
80,755 | $7,600,660 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
53,365 | $5,189,746 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,600,660 | 80,755 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,094,312 | 41,453 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $2,832,229 | 33,395 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $2,198,880 | 32,289 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $2,916,148 | 48,161 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $3,417,445 | 49,478 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $3,034,188 | 45,903 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $2,738,993 | 45,183 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $2,434,157 | 42,727 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $2,147,480 | 34,201 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $1,646,271 | 28,497 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $1,660,269 | 26,671 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $1,188,696 | 16,448 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $1,450,177 | 18,055 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $1,094,028 | 16,417 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $1,247,199 | 16,417 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $1,381,669 | 17,397 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $1,344,100 | 18,312 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $1,947,918 | 28,321 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $3,199,295 | 38,028 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $3,861,869 | 47,519 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $4,133,202 | 47,519 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $5,142,012 | 57,299 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $5,730,098 | 55,113 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $2,982,877 | 40,733 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||